Business
Investor buzz around cannabis stocks with new treatments – Sydney Morning Herald
Cannabis startups get down to business as treatments normalised and some small stocks are winning big name backers.
Last week ASX-listed Zelira Therapeutics, formerly Zelda Therapeutics, scored a new substantial shareholder when billionaire investor Alex Waislitz’s Thorney Investment Group upped its stake from 2 per cent to 5.2 per cent.
Earlier this month Zelira confirmed its cannabinoid insomnia medicine Zenivol had been made available in Australia under the nation’s special access scheme for cannabis products.
Thorney bumped its stake after a private placement of 37 million shares at 5.4c each.
“The str…
-
Noosa News11 hours agoWoman and two boys killed in Gladstone house fire identified
-
Noosa News10 hours agoADF soldier dies in vehicle rollover during Townsville training exercise
-
General24 hours agoFormer Alice Springs principal Gavin Morris guilty on four counts of aggravated assault against students
-
Noosa News12 hours agoSoldiers airlifted to Townsville University Hospital after ADF crash